FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:828-830 February 24, 2005 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Mayer, S. A. PubMed Citation

Beyond aggressive supportive care, clinicians have not had specific treatments to offer patients with intracerebral hemorrhage. The article by Mayer et al.¹ in this issue of the Journal offers new hope for targeted therapy for this frequent cause of neurologic disability and death. Intracerebral hemorrhage is estimated to account for 10 to 15 percent of all strokes and to have a one-year mortality greater than 60 percent.² In the Far East, intracerebral hemorrhage is even more common, accounting for almost 30 percent of strokes in China.³ Approximately 37,000 to 52,000 cases of intracerebral hemorrhage occur in the United States each . . . [Full Text of this Article]

Source Information

From the Stroke Program, University of Michigan Health System, Ann Arbor.

This article has been cited by other articles:

• Fric-Shamji, E. C., Shamji, M. F., Cole, J., Benoit, B. G. (2008). Modifiable risk factors for intracerebral hemorrhage: Study of anticoagulated patients. cfp 54: 1138-1139.e4 [Abstract] [Full Text]  
• Kim, J., Smith, A., Hemphill, J.C. III, Smith, W.S., Lu, Y., Dillon, W.P., Wintermark, M. (2008). Contrast Extravasation on CT Predicts Mortality in Primary Intracerebral Hemorrhage. Am. J. Neuroradiol. 29: 520-525 [Abstract] [Full Text]  
• Broderick, J., Connolly, S., Feldmann, E., Hanley, D., Kase, C., Krieger, D., Mayberg, M., Morgenstern, L., Ogilvy, C. S., Vespa, P., Zuccarello, M. (2007). REPRINT: Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.. Circulation 116: e391-e413 [Abstract] [Full Text]  
• Broderick, J., Connolly, S., Feldmann, E., Hanley, D., Kase, C., Krieger, D., Mayberg, M., Morgenstern, L., Ogilvy, C. S., Vespa, P., Zuccarello, M. (2007). Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.. Stroke 38: 2001-2023 [Abstract] [Full Text]  
• Takahashi, O., Cook, E.F., Nakamura, T., Saito, J., Ikawa, F., Fukui, T. (2006). Risk stratification for in-hospital mortality in spontaneous intracerebral haemorrhage: A Classification and Regression Tree Analysis. QJM 99: 743-750 [Abstract] [Full Text]  
• Juvela, S., Kase, C. S. (2006). Advances in Intracerebral Hemorrhage Management. Stroke 37: 301-304 [Full Text]  
• Dzik, W. H. (2006). Off-label Reports of New Biologics: Exciting New Therapy or Dubious Research? Examples From Recombinant Activated Factor VII. J Intensive Care Med 21: 54-59  
• Kase, C. S. (2005). Hemostatic Treatment in the Early Stage of Intracerebral Hemorrhage: The Recombinant Factor VIIa Experience. Stroke 36: 2321-2322 [Full Text]  
• (2005). Recombinant Factor VII for Patients with Intracerebral Hemorrhage. JWatch General 2005: 1-1 [Full Text]